Related references
Note: Only part of the references are listed.Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
Heather Torrey et al.
SCIENCE SIGNALING (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
Heather Torrey et al.
SCIENCE SIGNALING (2017)
A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy That Is Further Enhanced in Combination with an OX40 Agonist
Rebecca Leyland et al.
CLINICAL CANCER RESEARCH (2017)
Targeting latency-associated peptide promotes antitumor immunity
Galina Gabriely et al.
SCIENCE IMMUNOLOGY (2017)
The role of GITR single-positive cells in immune homeostasis
Giuseppe Nocentini et al.
IMMUNITY INFLAMMATION AND DISEASE (2017)
Ovarian carcinoma-infiltrating regulatory T cells were more potent suppressors of CD8+ T cell inflammation than their peripheral counterparts, a function dependent on TIM3 expression
Meimei Bu et al.
TUMOR BIOLOGY (2016)
Profiling networks of distinct immune-cells in tumors
Trevor Clancy et al.
BMC BIOINFORMATICS (2016)
Anti-GITR therapy promotes immunity against malignant glioma in a murine model
Jason Miska et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Rationale for anti-GITR cancer immunotherapy
Deborah A. Knee et al.
EUROPEAN JOURNAL OF CANCER (2016)
Modulation of tumor immunity: a patent evaluation of WO2015026684A1
Giuseppe Nocentini et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Immune checkpoint inhibitors: a patent review (2010-2015)
Matthieu Collin
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Targeting regulatory T cells in tumors
Chang Liu et al.
FEBS JOURNAL (2016)
Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells
Marco De Simone et al.
IMMUNITY (2016)
Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer
George Plitas et al.
IMMUNITY (2016)
Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients
May Abd Al Samid et al.
Oncotarget (2016)
Regulatory T Cells: Differentiation and Function
George Plitas et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht et al.
GENOME BIOLOGY (2016)
The head and neck cancer immune landscape and its immunotherapeutic implications
Rajarsi Mandal et al.
JCI INSIGHT (2016)
GITR+ regulatory T cells in the treatment of autoimmune diseases
Maria Grazia Petrillo et al.
AUTOIMMUNITY REVIEWS (2015)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
TIGIT predominantly regulates the immune response via regulatory T cells
Sema Kurtulus et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Authentic GITR Signaling Fails To Induce Tumor Regression unless Foxp3+ Regulatory T Cells Are Depleted
Young H. Kim et al.
JOURNAL OF IMMUNOLOGY (2015)
Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226
Christopher A. Fuhrman et al.
JOURNAL OF IMMUNOLOGY (2015)
Identification and characterization of latency-associated peptide-expressing γδ T cells
Rafael M. Rezende et al.
NATURE COMMUNICATIONS (2015)
Apoptosis of tumor infiltrating effector TIM-3+CD8+T cells in colon cancer
Chiao-Wen Kang et al.
SCIENTIFIC REPORTS (2015)
Glucocorticoid-Induced Tumour Necrosis Factor Receptor-Related Protein: A Key Marker of Functional Regulatory T Cells
Simona Ronchetti et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
CD39: A complementary target to immune checkpoints to counteract tumor-mediated immunosuppression
Nathalie Bonnefoy et al.
ONCOIMMUNOLOGY (2015)
ArrayExpress update-simplifying data submissions
Nikolay Kolesnikov et al.
NUCLEIC ACIDS RESEARCH (2015)
Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?
Theresa L. Whiteside
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Induced regulatory T cells in inhibitory microenvironments created by cancer
Theresa L. Whiteside
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses
Nicole Joller et al.
IMMUNITY (2014)
Galectin-9-CD44 Interaction Enhances Stability and Function of Adaptive Regulatory T Cells
Chuan Wu et al.
IMMUNITY (2014)
Genetic and epigenetic basis of Treg cell development and function: from a FoxP3-centered view to an epigenome-defined view of natural Treg cells
Hiromasa Morikawa et al.
IMMUNOLOGICAL REVIEWS (2014)
tTregs, pTregs, and iTregs: similarities and differences
Ethan M. Shevach et al.
IMMUNOLOGICAL REVIEWS (2014)
OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy
Yannick Bulliard et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies
Shravan Madireddi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Highly prevalent colorectal cancer-infiltrating LAP+ Foxp3- T cells exhibit more potent immunosuppressive activity than Foxp3+ regulatory T cells
M. Scurr et al.
MUCOSAL IMMUNOLOGY (2014)
Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells
Shawn A. Mahmud et al.
NATURE IMMUNOLOGY (2014)
In Vivo Targeting of Intratumor Regulatory T Cells Using PEG-Modified Single-Walled Carbon Nanotubes
Cristiano Sacchetti et al.
BIOCONJUGATE CHEMISTRY (2013)
Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+Tregs within the tumor microenvironment
Chindu Govindaraj et al.
CLINICAL IMMUNOLOGY (2013)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
Aurelien Marabelle et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies
Yannick Bulliard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma
Tyler R. Simpson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells
Nicola Gagliani et al.
NATURE MEDICINE (2013)
Glucocorticoid-induced tumor necrosis factor receptor expression in patients with cervical human papillomavirus infection
Cacilda Tezelli Junqueira Padovani et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2013)
Digital Genomic Quantification of Tumor-Infiltrating Lymphocytes
Harlan S. Robins et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells
Mark J. Selby et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Convergences and divergences of tnymus- and peripherally derived regulatory T cells in cancer
Alessia Burocchi et al.
FRONTIERS IN IMMUNOLOGY (2013)
Natural and induced T regulatory cells in cancer
Dennis O. Adeegbe et al.
FRONTIERS IN IMMUNOLOGY (2013)
Phenotypic and functional characteristics of CD4+CD39+FOXP3+ and CD4+CD39+FOXP3neg T-cell subsets in cancer patients
Patrick J. Schuler et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors
Heba A. Alshaker et al.
CANCER CELL INTERNATIONAL (2011)
CD4+CD25lowGITR+ cells: A novel human CD4+ T-cell population with regulatory activity
Rodolfo Bianchini et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
Nicole Joller et al.
JOURNAL OF IMMUNOLOGY (2011)
Phenotypical and functional specialization of FOXP3+ regulatory T cells
Daniel J. Campbell et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Tumor Necrosis Factor Receptor Expression and Signaling in Renal Cell Carcinoma
Rafia S. Al-Lamki et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation
Adam D. Cohen et al.
PLOS ONE (2010)
Foxp3+ regulatory T cells: differentiation, specification, subphenotypes
Markus Feuerer et al.
NATURE IMMUNOLOGY (2009)
GARP (LRRC32) is essential for the surface expression of latent TGF-β on platelets and activated FOXP3+ regulatory T cells
Dat Q. Tran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Latency-associated peptide identifies a novel CD4+CD25+ regulatory T cell subset with TGFβ-mediated function and enhanced suppression of experimental autoimmune encephalomyelitis
Mei-Ling Chen et al.
JOURNAL OF IMMUNOLOGY (2008)
Tregs and rethinking cancer immunotherapy
Tyler J. Curiel
JOURNAL OF CLINICAL INVESTIGATION (2007)
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells
K Ko et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Latent transforming growth factor-β (TGF-β) binding proteins:: Orchestrators of TGF-β availability
DB Rifkin
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3
WJ Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells
ACP Diederichsen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
UK Liyanage et al.
JOURNAL OF IMMUNOLOGY (2002)
Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4+ T-regulatory cells and systemic collapse of antitumour immunity
N Seo et al.
IMMUNOLOGY (2001)
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
RA Clynes et al.
NATURE MEDICINE (2000)
Share Paper
